跳转至内容
Merck
CN

SML1392

Sigma-Aldrich

FDI-6

≥98% (HPLC)

登录查看公司和协议定价

别名:
3-氨基-N-(4-氟苯基)-6-(2-噻吩基)-4-(三氟甲基)-噻吩并[2,3-b]吡啶-2-羧酰胺, 3-氨基-N-(4-氟苯基)-6-(噻吩-2-基)-4-(三氟甲基)噻吩并[2,3-b]吡啶-2-羧酰胺, NCGC00099374
经验公式(希尔记法):
C19H11F4N3OS2
分子量:
437.43
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

质量水平

检测方案

≥98% (HPLC)

形式

powder (flocculent)

颜色

white to beige

溶解性

DMSO: 10 mg/mL, clear

储存温度

2-8°C

SMILES字符串

NC1=C(C(NC2=CC=C(F)C=C2)=O)SC3=C1C(C(F)(F)F)=CC(C4=CC=CS4)=N3

InChI

1S/C19H11F4N3OS2/c20-9-3-5-10(6-4-9)25-17(27)16-15(24)14-11(19(21,22)23)8-12(26-18(14)29-16)13-2-1-7-28-13/h1-8H,24H2,(H,25,27)

InChI key

ZATJMMZPGVDUOM-UHFFFAOYSA-N

生化/生理作用

FDI-6是FOXM1的一种有效且特异性抑制剂,其可可阻止DNA的结合。FDI-6可与FOXM1蛋白结合,并特异性下调FOXM1激活的基因。
叉头结构域抑制剂6(FDI-6)可用于治疗因血液生成减少而导致贫血的患者。在Hep-2细胞中,FDI-6可以刺激细胞死亡,还有助于防止细胞增殖、侵袭和迁移。

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Forkhead domain inhibitor-6 (FDI-6) increases apoptosis and inhibits invasion and migration of laryngeal carcinoma cells by down-regulating nuclear FoxM1
Liu Y, et al.
Chinese Journal of Catalysis, 33(5), 611-616 (2017)
Loss of Forkhead box M1 promotes erythropoiesis through increased proliferation of erythroid progenitors
Youn M, et al.
Haematologica, 102(5), 826-834 (2017)
Karan Ulhaka et al.
International journal of molecular sciences, 22(13) (2021-07-03)
Triple-negative breast cancer (TNBC) presents an important clinical challenge, as it does not respond to endocrine therapies or other available targeting agents. FOXM1, an oncogenic transcriptional factor, has reported to be upregulated and associated with poor clinical outcomes in TNBC
Andrew P Sawaya et al.
Nature communications, 11(1), 4678-4678 (2020-09-18)
Diabetic foot ulcers (DFUs) are a life-threatening disease that often result in lower limb amputations and a shortened lifespan. However, molecular mechanisms contributing to the pathogenesis of DFUs remain poorly understood. We use next-generation sequencing to generate a human dataset
Susana Ros et al.
Cancer cell, 38(4), 516-533 (2020-09-26)
PIK3CA, encoding the PI3Kα isoform, is the most frequently mutated oncogene in estrogen receptor (ER)-positive breast cancer. Isoform-selective PI3K inhibitors are used clinically but intrinsic and acquired resistance limits their utility. Improved selection of patients that will benefit from these

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门